Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Suzuki

Showing results (741-750 of 752) with videos related to

Pageof 76
Sort By:
Respiratory Research|November 15, 2022
Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort studyKensuke Nakagawara, Shotaro Chubachi, Ho Namkoong, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 13, 2026
Nationwide surveillance of antibacterial susceptibility patterns of bacterial pathogens isolated from otorhinolaryngological infectious diseases in JapanHisakazu Yano, Kenji Suzuki, Yosuke Kamide, et al.
Clinical and Experimental Nephrology|April 22, 2018
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|March 9, 2020
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Open Forum Infectious Diseases|July 13, 2023
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task ForceHiromu Tanaka, Shotaro Chubachi, Ho Namkoong, et al.
Clinical and Experimental Nephrology|June 21, 2020
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
BMJ Open Respiratory Research|November 27, 2021
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocolKensuke Nakagawara, Ho Namkoong, Hideki Terai, et al.
Respiratory Investigation|October 2, 2023
Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort studyHideki Terai, Makoto Ishii, Ryo Takemura, et al.
Pageof 76

Showing results (741-750 of 752) with videos related to

Sort By:
Pageof 76
Respiratory Research|November 15, 2022
Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort studyKensuke Nakagawara, Shotaro Chubachi, Ho Namkoong, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 13, 2026
Nationwide surveillance of antibacterial susceptibility patterns of bacterial pathogens isolated from otorhinolaryngological infectious diseases in JapanHisakazu Yano, Kenji Suzuki, Yosuke Kamide, et al.
Clinical and Experimental Nephrology|April 22, 2018
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort studyRyohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Clinical and Experimental Nephrology|March 9, 2020
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, et al.
Open Forum Infectious Diseases|July 13, 2023
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task ForceHiromu Tanaka, Shotaro Chubachi, Ho Namkoong, et al.
Clinical and Experimental Nephrology|June 21, 2020
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
BMJ Open Respiratory Research|November 27, 2021
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocolKensuke Nakagawara, Ho Namkoong, Hideki Terai, et al.
Respiratory Investigation|October 2, 2023
Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort studyHideki Terai, Makoto Ishii, Ryo Takemura, et al.
Pageof 76